AVONDALE, Pa., Sept. 23, 2017 /PRNewswire/ -- Today, Qfix
announced the release of the first-in-its-class kVue™ Access
360™ G2 and Access™ Prone G2 positioning devices that
promise to improve prone breast cancer treatment by significantly
reducing radiation dose to healthy tissue while improving patient
comfort and reproducible positioning.
By allowing breast tissue to fall away from the chest wall as
patients lay face down, prone positioning can reduce radiation
exposure to the heart and lungs by as much as 90%.1
Prone positioning can also improve the uniformity of dose delivery
as well as treatment accuracy by reducing respiratory
motion.2
The open design of the kVue Access 360 G2 and Access Prone G2
devices enhances prone breast cancer treatment through precise
patient positioning and open access for greater flexibility in
treatment planning. Both devices connect to the couch top of the
radiotherapy machine and allow gravity to pull the breast away from
the chest wall, sparing healthy tissue and creating a uniform shape
that enables a more even dose distribution and improved cosmetic
outcomes. Compared to other approaches that achieved successful
cosmetic outcomes in 60-70% of cases, prone breast treatment with
Qfix's positioning technology resulted in successful cosmetic
outcomes in 80-90% of the cases.1
Qfix's kVue Access 360 G2 is designed to allow breast cancer
treatment for both the left and right breast. This one-of-a-kind
positioning solution inserts directly onto the couch top. The
absence of a conventional couch top below the insert eliminates
scatter and skin dose. The kVue Access 360 G2 also includes an
expanded supraclavicular grid, which provides full access to treat
the supraclavicular nodes in one set-up.
The Access Prone G2 device is CT and MR compatible to guide
patients seamlessly from simulation through treatment. Foam padding
increases patient comfort and removable inserts can be positioned
for either left or right breast treatment. These inserts also
feature low electron generating technology, minimizing skin dose
and redefining the gold standard for low attenuating devices. The
Access Prone G2 will be featured in the "Postlumpectomy Breast
Irradiation in the Prone Position" course to be presented by
Julia White, M.D., FACR, FASTRO, and
Tina LaPaglia, B.S.R.T., R.T.(R)(T),
during the 41st American Society of Radiologic Technologists (ASRT)
Radiation Therapy Conference, Tuesday,
September 26th, from 10:10-11:10
a.m. in the Novice Room at the Manchester Grand Hyatt in
San Diego, CA.
The new kVue Access 360 G2 and Access Prone G2 devices will be
on display with live demonstrations in the Qfix booth #735 during
the American Society for Radiation Oncology (ASTRO) annual meeting,
September 24 – 26, 2017, at the
San Diego Convention Center.
About Qfix
Qfix (www.Qfix.com) is a world leader in
radiotherapy dedicated to helping medical professionals provide the
best patient care with the world's finest positioning devices to
enhance the probability of positive patient outcomes. For more
information, visit www.Qfix.com.
SOURCE: Qfix
1. Santos, Isaura. "Breast Cancer Radiation Therapy In Prone
Position Reduces Toxic Side Effects." Radiation Therapy News
(2014).
https://radiationtherapynews.com/2014/10/16/breast-cancer-radiation-therapy-prone-position-reduces-toxic-side-effects/
2. Buijsen, Jeroen, et al. "Prone Breast Irradiation for
Pendulous Breasts." Radiotherapy and Oncology: Journal of the
European Society for Therapeutic Radiology and Oncology 82.3
(2007): 337-40. Print; Croog, Victoria J., et al. "Accelerated
Whole Breast Irradiation with Intensity-Modulated Radiotherapy to
the Prone Breast." IJROBP 73.1 (2009): 88-93. Print; DeWyngaert, J.
Keith, et al. "Accelerated Intensity-Modulated Radiotherapy to
Breast in Prone Position: Dosimetric Results." IJROBP 68.4 (2007):
1251-59. Print.
View original
content:http://www.prnewswire.com/news-releases/qfix-launches-new-radiotherapy-positioning-technology-for-the-more-precise-treatment-of-breast-cancer-300524705.html
SOURCE Qfix